Published in Oncotarget on December 22, 2016
AMPK: a novel target for treating hepatic fibrosis. Oncotarget (2017) 0.75
Magnesium gates glutamate-activated channels in mouse central neurones. Nature (1984) 13.67
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science (1997) 10.90
Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature (1984) 9.22
Persistent pain and well-being: a World Health Organization Study in Primary Care. JAMA (1998) 6.44
Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother (1957) 6.28
Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron (1998) 5.05
The role of divalent cations in the N-methyl-D-aspartate responses of mouse central neurones in culture. J Physiol (1988) 4.91
NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones. Nature (1986) 4.88
Ryanodine modifies conductance and gating behavior of single Ca2+ release channel. Am J Physiol (1987) 4.61
Calcium regulation of neuronal gene expression. Proc Natl Acad Sci U S A (2001) 4.31
Chronic pain in Australia: a prevalence study. Pain (2001) 3.83
N-methyl-D-aspartic acid receptor structure and function. Physiol Rev (1994) 3.08
A caffeine- and ryanodine-sensitive Ca2+ store in bullfrog sympathetic neurones modulates effects of Ca2+ entry on [Ca2+]i. J Physiol (1992) 2.83
Requirement for BDNF in activity-dependent survival of cortical neurons. Science (1994) 2.64
Mechanisms of disease: neuropathic pain--a clinical perspective. Nat Clin Pract Neurol (2006) 2.44
Are sirtuins viable targets for improving healthspan and lifespan? Nat Rev Drug Discov (2012) 2.22
The brain ryanodine receptor: a caffeine-sensitive calcium release channel. Neuron (1991) 2.05
Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem (1998) 1.87
Postsynaptic secretion of BDNF and NT-3 from hippocampal neurons depends on calcium calmodulin kinase II signaling and proceeds via delayed fusion pore opening. J Neurosci (2007) 1.52
Resveratrol facilitates pain attenuation in a rat model of neuropathic pain through the activation of spinal Sirt1. Reg Anesth Pain Med (2013) 1.50
Pre- and postsynaptic contributions of voltage-dependent Ca2+ channels to nociceptive transmission in rat spinal lamina I neurons. Eur J Neurosci (2004) 1.42
Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: descending monoamine system and opioid receptors are differentially involved. Neuropharmacology (2011) 1.29
Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia. Pain (2000) 1.22
Differential effects of protein synthesis inhibition on the activity-dependent expression of BDNF transcripts: evidence for immediate-early gene responses from specific promoters. J Neurosci (1996) 1.21
Antinociceptive effects of Ca2+ channel blockers. Eur J Pharmacol (1992) 1.18
Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system. Eur Neuropsychopharmacol (2010) 1.04
Ca2+/calmodulin-dependent protein kinase II in the spinal cord contributes to neuropathic pain in a rat model of mononeuropathy. Eur J Neurosci (2005) 1.01
Comparative studies of the antioxidant effects of cis- and trans-resveratrol. Curr Med Chem (2006) 1.01
Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur J Biochem (1999) 0.99
Localization of CaMKIIalpha in rat primary sensory neurons: increase in inflammation. Brain Res (2002) 0.99
Future directions in neuropathic pain therapy: closing the translational loop. Oncologist (2010) 0.92
Pharmacologic studies on analgesics. VII. Significance of the calcium ion in morphine analgesia. J Pharmacol Exp Ther (1966) 0.91
Analgesic effects of diltiazem and verapamil after central and peripheral administration in the hot-plate test. Gen Pharmacol (1990) 0.89
Ca(2+)/calmodulin-protein kinase IIalpha in the trigeminal subnucleus caudalis contributes to neuropathic pain following inferior alveolar nerve transection. Exp Neurol (2005) 0.89
Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Fundam Clin Pharmacol (2007) 0.89
Antinociceptive effects of intrathecally administered huwentoxin-I, a selective N-type calcium channel blocker, in the formalin test in conscious rats. Toxicon (2005) 0.88
Effects of elevated calcium and calcium antagonists on 6,7-benzomorphan-induced analgesia. Eur J Pharmacol (1983) 0.88
alpha2-adrenoceptors inhibit the intracellular Ca2+ response to electrical stimulation in normal and injured sensory neurons, with increased inhibition of calcitonin gene-related peptide expressing neurons after injury. Neuroscience (2005) 0.88
Inhibition of Ca2+/calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in rats. Mol Pain (2012) 0.84
Involvement of calcium in pain and antinociception. Braz J Med Biol Res (2001) 0.83
Tolerance induced by non-opioid analgesic microinjections into rat's periaqueductal gray and nucleus raphe. Georgian Med News (2010) 0.83
Calcium modulation of morphine analgesia: role of calcium channels and intracellular pool calcium. J Pharmacol Exp Ther (1995) 0.81
Role of intracellular calcium in acute thermal pain perception. Neuropharmacology (2004) 0.80
Modification of endorphin/enkephalin analgesia and stress-induced analgesia by divalent cations, a cation chelator and an ionophore. Br J Pharmacol (1982) 0.80
Effects of intrathecally administered aminoglycoside antibiotics, calcium-channel blockers, nickel and calcium on acetic acid-induced writhing test in mice. Gen Pharmacol (1998) 0.79
Hyperalgesic effects of divalent cations and antinociceptive effects of a calcium chelator in naive and morphine-dependent mice. J Pharmacol Exp Ther (1980) 0.79
Characterization of brain-type ryanodine receptor permanently expressed in Chinese hamster ovary cells. Life Sci (1998) 0.79
Analgesic effects of intracerebroventricular administration of calcium channel blockers in mice. Gen Pharmacol (1993) 0.78
Red wine, grapes, and better health--resveratrol. Nutr Clin Pract (2011) 0.78
[Voltage-dependent calcium channels at the heart of pain perception]. Med Sci (Paris) (2006) 0.77
Interactions between analgesics and calcium channel blockers. Gen Pharmacol (1990) 0.76
Buspirone-induced antinociception is mediated by L-type calcium channels and calcium/caffeine-sensitive pools in mice. Psychopharmacology (Berl) (2003) 0.76
Differential effects of divalent cations, cation chelators and an ionophore (A23187) on morphine and dibutyryl guanosine 3': 5'-cyclic monophosphate antinociception. J Pharmacol Exp Ther (1980) 0.76
Mechanical and thermal anti-nociception in rats after systemic administration of verapamil. Neurosci Lett (2004) 0.76
Nitric oxide in the hippocampal cortical area interacts with naloxone in inducing pain. Indian J Pharmacol (2012) 0.76
Hypotension does not alter the antinociceptive effect of nifedipine. Life Sci (1998) 0.76
The role of nitric oxide on the oxytocin induce analgesia in mice. Iran J Basic Med Sci (2016) 0.76